Companies / Alto Neuroscience

Alto Neuroscience

Mountain View, United States

Alto Neuroscience develops biology-driven medicines for neuropsychiatric conditions

Alto Neuroscience, based in Mountain View, United States, has 8 investors on file, among them Able Partners, InVivium Capital and Korify Capital. Its latest round on record is Round, 16 Mar 2026. Its site was last checked 12 Nov 2026: site answers.

altoneuroscience.com

Funding

1 round on record

Latest roundRound16 Mar 2026

Since that round8 monthsno later round on record

Investors in its rounds71 with a VCinfo profile

Mar 2026RoundLed by Commodore Capital, with Venrock and 5 others

Round sizes and total raised are on Fundup AI, our sister product for funding data.

SEC Form D filings

5 filings

$50.0M sold27 Oct 2025 $45.0M sold27 Nov 2023 $59.3M sold27 Nov 2023 $31.9M sold27 Nov 2023 $7.7M sold27 Nov 2023

Filed by Alto Neuroscience, Inc. with the SEC. A Form D reports a private offering; it is not a priced round.

Investors

8 investors on file

Investor	Evidence	Type
Able Partners	Portfolio page	Venture capital
InVivium Capital	Portfolio page	Venture capital
Korify Capital	Portfolio page	Venture capital
StartX	Portfolio page	Accelerator
Valor Siren Ventures	Portfolio page	Venture capital
Venrock	Portfolio page	Venture capital
Vivo Capital	Portfolio page	Venture capital
What If Ventures	Portfolio page	Venture capital

In the news

2 headlines naming Alto Neuroscience

11 Nov 2026

Alto Neuroscience faces pivotal 2027 as Jefferies flags three clinical catalystsproactiveinvestors.com 11 Nov 2026

BTIG Research Reaffirms Buy Rating for Alto Neuroscience (NYSE:ANRO)tickerreport.com

Each headline is matched with evidence and opens on its outlet. Some come through the GDELT Project.

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

At a glance

Latest round: Round, 16 Mar 2026
Investors on file: 8
Founded: 2019
Employees: 51-200
Headquarters: Mountain View, United States
Open roles: 6
Site: Answers
Last checked: 12 Nov 2026

Company data by Fundup AI. Also from Wikidata.

Backed by the same investors

Companies sharing two or more investors with Alto Neuroscience.

Compass Pathways2 shared

Eco2 shared

Expedition Therapeutics2 shared

Glyphic Biotechnologies2 shared

Immune-Onc Therapeutics2 shared

Neros2 shared

Get this company as JSON

GET /v1/companies/altoneuroscience.com
GET /v1/companies/altoneuroscience.com/investors
GET /v1/companies/altoneuroscience.com/news

API docs · Get a free key · Your API key

Raising a round?

See which investors fit your startup, ranked by what they actually back.

Check investor fit

Free account · no card

Get Alto Neuroscience and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Able Partners adds a company.

Work email, sign-in link by email. Already have an account? Log in

Your API key Read the docs

Ask AI5 plain-English investor searches a day
Full listsEvery portfolio row and two-firm overlap
API and MCP100 REST or MCP calls a month, one key
AlertsFollow 5 investors for portfolio and fund changes

VCinfo API

$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/altoneuroscience.com/investors

# also
GET /v1/companies/altoneuroscience.com
GET /v1/companies/altoneuroscience.com/news

The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing